Get the latest news on Sihuan Pharma Hldgs gr stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on SHPHY performance

Latest Sihuan Pharma Hldgs gr Stock News | OTC:SHPHY | Benzinga

Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.

SIHUAN PHARM HLDGS ADR by Sihuan Pharmaceutical Holdings Group Ltd.

Comments

Sihuan Pharma Hldgs gr Stock News

News

Latest Sihuan Pharma Hldgs gr Stock News | OTC:SHPHY | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga